Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WVU011625: The Role of Scheduled Intravenous Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck Cancer

NCT07784855 is registered in ClinicalTrials.gov with West Virginia University as lead sponsor.

NCT NCT07784855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WVU011625: The Role of Scheduled Intravenous Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck Cancer
Lead sponsor
West Virginia University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
April 30, 2029
Enrollment
180 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of hypopharynx, squamous cell carcinoma of larynx, squamous cell carcinoma of oral cavity, squamous cell carcinoma of oropharynx